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Abstract
Background—A previous study has sug-
gested an increased incidence rate of
leukaemia from 1978 to 1992 in people
aged 0 to 24 years and living in the vicinity
of the La Hague nuclear waste reprocess-
ing plant without considering age and
cytological type.
Setting—The Nord Cotentin region
(France) and the island of Alderney
(United Kingdom).
Study objective—To describe the occur-
rence of leukaemia for each age group and
cytological type from 1978 to 1998 in the
same area, using accurate reference inci-
dence rates and adequate estimation of
the at risk population.
Design—A geographical study of inci-
dence using three zones defined according
to their distance from the site (0 to 10 km:
Beaumont-Hague electoral ward, 10 to 20
km and 20 to 35 km) has been conducted.
The risk of leukaemia was estimated from
the standardised incidence ratio (SIR) of
the number of cases observed to the
number expected. Exact 95% confidence
intervals (CI) have been computed.
Participants—All people under the age of
25 years living in the study region between
1978 and 1998.
Main results—The observed number of
cases of leukaemia in the study region as a
whole was consistent with the expected
value (SIR=1.03; 95%CI: 0.73, 1.41). No
cases were observed on Alderney. The SIR
in the Beaumont-Hague electoral ward
was 2.17 (95%CI: 0.71, 5.07). The highest
SIR was observed in the 5 to 9 years age
group (SIR=6.38; 95%CI: 1.32, 18.65). This
consists in acute lymphoblastic leukaemia
cases.
Conclusion—This study indicates an in-
creased incidence of leukaemia in the area
situated at less than 10 km from the plant.
Monitoring and further investigations
should be targeted at acute lymphoblastic
leukaemia occurring during the childhood
incidence peak (before 10 years) in chil-
dren living near the La Hague site and
may be other nuclear reprocessing plants.
(J Epidemiol Community Health 2001;55:469–474)
The Nord Cotentin region of France has a par-
ticularly high density of nuclear installations.
The La Hague nuclear waste reprocessing
plant, a surface storage facility for nuclear
waste, the Flamanville nuclear power station
and the Cherbourg military arsenal are all
within 20 km of each other.
The clusters of leukaemia in children and
young adults discovered near the nuclear
reprocessing plants of Sellafield (England)1 and
Dounreay (Scotland)2 have been largely inves-
tigated. Complete overviews, emphasing the
crucial role of population movements, have
been recently published.3 4 In France, several
epidemiological studies were conducted to
analyse the mortality rate attributable to
leukaemia or the leukaemia incidence among
children and young adults living in the vicinity
of the La Hague reprocessing plant.5–7 The
incidence of leukaemia between 1978 and
1992 in the Beaumont-Hague electoral ward
(10 709 inhabitants in 1990), in which the
plant is situated was found to be higher than
expected (4 cases observed versus 1.4 ex-
pected; standardised incidence ratio (SIR)
=2.8; 95% confidence intervals (95%CI): 0.8,
7.2).7 In this paper, the expected numbers of
cases were calculated with reference rates
based on small population size and short
period (1978–1982) and person years were
estimated by linear interpolation and extrapo-
lation methods. This observation led to a case-
control study that showed that the occurrence
of leukaemia was associated with the mother,
while pregnant, or the children themselves,
going to the beach, and the children eating
locally caught fish and shellfish.8 These find-
ings have been much debated especially
concerning choice of the controls, possible
recall bias, number of associations tested and
interpretation of the results.9–13 They reinforced
the misgivings of the local population.
The La Manche cancer register (ARKM)
has been collecting extensive data on sex, age,
cytological type and case history in the “dépar-
tement” (county) since 1994. It has also access
to a professional relations network allowing the
incidence of child and young adult leukaemia
in Nord Cotentin to be determined retrospec-
tively. In the context of an increased childhood
and young adulthood leukaemia incidence rate
in the small Beaumont-Hague electoral ward,
the aim of this study was first to extend the
surveillance time period by 40% and to
describe the incidence of leukaemia in the
Nord Cotentin region between 1978 and 1998,
with more accurate estimation of the expected
number. Secondly, the extension of the study
period permitted the data to be analysed by age
and cytological type, which provides guidance
for further aetiological investigations.
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The studied region lies within 35 km of the La
Hague nuclear reprocessing plant. It was
divided into three zones according to the
distance from the plant: 0 to 10 km
(Beaumont-Hague electoral ward), 10 to 20
km and 20 to 35 km.7 The incidence of leukae-
mia in the 0 to 24 year old age group living on
one of the Channel Islands, Alderney (UK),
situated at 15 km from the site was also inves-
tigated. The study period covered the years
1978 to 1998. Before 1978, patient files were
impossible to trace retrospectively.
COLLECTION AND VALIDATION OF CASES
Cases were all individuals aged between 0 and
24 years old diagnosed with leukaemia between
the 1 January 1978 and the 31 December
1998, and living in the study area when
diagnosed. Cases during the years 1978 to
1993 were identified by a retrospective survey
of the 194 doctors who had practised in the
study area at some time during the period.
Firstly, the 168 physicians (general practition-
ers and paediatricians) currently practising in
the area under study and in the five surround-
ing electoral wards were asked about cases of
leukaemia among their patients, the year when
they started to practise and the name of their
predecessor. A total of 167 replies were
obtained: 35 had been practising since before
1978; 103 between 1978 and 1993 and 19
since 1993. The replies also named 56
physicians practising in the area between 1978
and 1993 and who had subsequently retired or
moved. These doctors were also contacted.
The files of hospitals routinely providing
healthcare for the inhabitants of Nord Cotentin
were used, as were death certificate data. Cases
for the period from 1994 onwards were identi-
fied from the data of the La Manche cancer
register. Data for Alderney were collected from
the two general practitioners on the island.
The cytology of all available blood and/or
bone marrow samples was examined by one of
us (XT) to confirm diagnosis. Cases were
scored as acute lymphoblastic leukaemia, acute
myeloblastic leukaemia, chronic myeloid leu-
kaemia or unclassified acute leukaemia accord-
ing to the French-American-British classifi-
cation (FAB classification).14
POPULATION DATA
The following demographic data were supplied
by the “Institut National de la Statistique et des
Etudes Economiques” (INSEE) for each
French electoral ward: population by age and
sex for the years 1975, 1982, and 1990, the
total population in 1999, and numbers of
births and deaths by age and sex from 1975 to
1997. The population for each age, sex and
electoral ward was estimated for each year by
aging the population.15 Each of the age cohorts
was followed up from a census or from birth by
aging one year at a time, and subtracting the
number of deaths recorded. The result was
then corrected by applying the migratory flux
evenly over the period between censuses and
for each cohort.
The total population at risk in the 10
electoral wards and for the period studied was
1 287 566 person years (table 1).
For the island of Alderney, census data for
age and sex were obtained from the Economics
and Statistics Unit, Government of Guernsey,
for the years 1981, 1986, 1991 and 1996. In the
absence of more detailed data, linear interpola-
tions and extrapolations were used to estimate
the size of the inter-census populations (11 300
person years).
REFERENCE INCIDENCE RATES
Reference incidence rates for leukaemia were
calculated from published general population
French cancer registers (Bas-Rhin, Doubs and
Isère 1978–1992, Calvados 1978–1987, Haut-
Rhin 1988–1992).16–18 A single reference value
was calculated for each sex and five year age
group from the sums of cases and person years
of all the reference registers (table 2): for the 0
to 24 year old age group the world standardised
incidence was 3.42 per 100 000 person years
for boys and 2.59 per 100 000 person years for
girls.
The paediatric registers of Lorraine and of
the Provence-Alpes-Côte-d’Azur and Corsica
regions were also used as references for
children under 15 years old and for the analy-
sis according to type of leukaemia.19–21
STATISTICAL METHODS
It was decided a priori to analyse the data by
the following age bands: 0 to 4; 5 to 9; 10 to 14;
15 to 24. Acute lymphoblastic leukaemia cases
were separately considered for the 1 to 6 year
old age group, as this age group includes the
peak incidence reported for this condition.22 23
Table 1 Population at risk (person years), estimated by the diagonal method for the period
1978–1998, by age group, sex and zone in Nord Cotentin
Age (y) Sex
Distance from the plant
0 to 10 km 10 to 20 km 20 to 35 km Total (0 to 35 km)
0 to 4 Male 8 333 76 883 47 206 132 422
Female 7 926 73 854 45 451 127 231
Total 16 259 150 737 92 657 259 653
5 to 9 Male 8 899 73 016 51 303 133 218
Female 8 618 70 600 49 550 128 768
Total 17 517 143 616 100 853 261 986
10 to 14 Male 8 654 69 513 53 936 132 103
Female 8 312 67 407 52 317 128 036
Total 16 966 136 920 106 253 260 139
15 to 19 Male 7 833 68 230 53 367 129 430
Female 7 186 66 927 50 374 124 487
Total 15 019 135 157 103 741 253 917
20 to 24 Male 7 143 72 205 49 533 128 881
Female 6 521 70 247 46 222 122 990
Total 13 664 142 452 95 755 251 871
Total 0 to 24 Male 40 862 359 847 255 345 656 054
Female 38 563 349 035 243 914 631 512
Total 79 425 708 882 499 259 1 287 566
Table 2 Incidence of leukaemia (per 100 000 person years)
by sex and age group, calculated from 5 French registers
(Bas-Rhin, 1978–1992; Doubs, 1978–1992; Calvados,
1978–1987; Haut-Rhin, 1988–1992; Isère, 1978–1992)
Sex
Age (y)
0 to 4 5 to 9 10 to 14 15 to 19 20 to 24
Male 5.51 3.23 2.29 2.63 2.65
Female 4.65 2.11 2.22 1.68 1.55
Total 5.09 2.68 2.26 2.16 2.11
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The number of cases expected was calcu-
lated in the population in each zone studied by
applying the reference incidence for age and
sex. The risk of leukaemia in Nord Cotentin
was estimated from the ratio of the number of
cases observed to the number expected as a
SIR. The 95%CI for the SIR were calculated
assuming that the number of observed cases
followed a Poisson distribution (Stata 6.0
software, College Station, Texas). Confidence
intervals should not be considered as a test of
statistical significance but as numerical indices
providing guidance to the selection of impor-
tant patterns.24
Results
There were 38 cases (22 boys and 16 girls) of
leukaemia recorded between 1978 and 1998 in
the population of 0 to 24 year olds in the study
region (see table 3 for details). The first case
was diagnosed in 1979 and the last in 1998.
There were 23 cases of acute lymphoblastic
leukaemia (60.5%), eight of acute myeloblastic
leukaemia (21.1%), six of chronic myeloid leu-
kaemia (15.8%) and one of unclassified acute
leukaemia (2.6%). Five of the cases lived in the
Beaumont-Hague electoral ward, 16 in the 10
to 20 km zone and 13 in the 20 to 35 km zone.
Three of the cases were Down’s syndrome
patients, none of whom lived in the Beaumont-
Hague electoral ward. None of the 38 cases had
a known history of cancer, trisomy 8 syndrome,
Table 3 Description of leukaemia cases in people under 25 years between 1978 and 1998
in the study zone
Case







1 × 79 1 M AML
2 × 79 5 M AML
3 × 79 19 F CML
4 × 80 14 M ALL
5 × 80 24 M CML
6 × 81 6 M ALL
7 × 81 15 F CML
8 × 82 3 F ALL
9 × 83 6 F ALL
10 × 83 22 F AML
11 × 84 6 F ALL
12 × 84 14 F ALL
13 × 85 1 F AL
14 × 85 4 M ALL
15 × 85 8 F ALL
16 × 87 16 F ALL
17 × 87 3 M ALL
18 × 87 4 M ALL
19 × 87 5 F ALL
20 × 88 1 M ALL
21 × 88 23 M AML
22 × 89 5 M ALL
23 × 89 1 F ALL
24 × 90 12 M ALL
25 × 92 1 M ALL
26 × 93 2 M ALL
27 × 93 18 M CML
28 × 93 23 F CML
29 × 94 15 F CML
30 × 94 6 F ALL
31 × 95 12 F ALL
32 × 95 12 M AML
33 × 95 12 M ALL
34 × 97 14 M AML
35 × 97 0 M AML
36 × 97 20 M ALL
37 × 98 5 M ALL
38 × 98 15 M AML
*Zone : 1 : <10 km from the reprocessing plant; 2 : 10 to 20 km from the plant; 3 : 20 to 35 km
from the plant. †Type of leukaemia : ALL : acute lymphoblastic leukaemia; AML : acute myelob-
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Bloom syndrome, ataxia telangiectasia, Fan-
coni anaemia, Li-Fraumeni or immuno-
deficiency syndromes.
The expected total number of cases in the
study area was 36.93, and 38 cases were
observed (SIR=1.03; 95%CI: 0.73, 1.41)
(table 4). In the 0 to 10 km zone (Beaumont-
Hague), there were five cases whereas 2.30
were expected. The SIR for the entire 0 to 24
year old group was 2.17 (95%CI: 0.71, 5.07).
The highest SIR for an age group was for the 5
to 9 year olds: there were three cases observed
in this group although 0.47 were expected
(SIR=6.38; 95%CI: 1.32, 18.65). There was
no excess in number of cases for the 10 to 35
km zones for any sex or age group. In the 0 to
24 year old population of Alderney, there were
no cases of leukaemia.
Table 5 shows the results classified according
to type of leukaemia (acute lymphoblastic leu-
kaemia and acute myeloblastic leukaemia) for
children under the age of 15. The SIR was 5.77
for acute lymphoblastic leukaemia in the 5 to 9
year old age group (95%CI: 1.19, 16.86). All
three cases involved were boys born in the
“département” of La Manche. These cases
were diagnosed in 1981, 1989 and 1998.
Discussion
For the area studied as a whole, the number of
cases observed was consistent with the number
expected. When comparing the three areas
around the La Hague plant, the highest SIR of
leukaemia among people aged less than 25
years was observed in the 0 to 10 km area
(SIR=2.17; 95%CI: 0.71, 5.07). In this zone,
the highest SIR concerned the 5 to 9 year olds.
These cases were three children aged 5 or 6 and
suVering acute lymphoblastic leukaemia.
Of the 194 doctors practising in the area at
some time during the study period, nine
(4.6%) were dead, four (2.1%) could not be
traced, and 23 (11.9%) did not reply. The
highest response rates were in the zones less
than 10 km and 10 to 20 km from the plant
(83.3% and 86.7% respectively). The response
rate was 76.9% for the 20 to 35 km zone and
73.7% for the surrounding area, and these
relatively low response rates raise the possibility
of underascertainment of cases in these areas.
It is likely, in any event, that physicians with no
cases to report would tend to be found among
the non-responders. The files of the usual
healthcare system were used, as far as possible,
to validate the data, but are not exhaustive for
the earlier part of the period under study. All
the diagnoses were validated by the same
investigator who had no information about the
patient (sex, age or place of residence).
In France, general population cancer regis-
ters cover the population of a “département”,
with the consequence that the population sizes
are small. The reference values used were
calculated by combining data from registers
from five “départements” in which the inci-
dence rates of cancer are stable over time.
There are also three registers in France record-
ing paediatric cancer (under 15 years old).
According to these paediatric registers, the
expected number of cases in the under 15 year
old group in our study is 32.42, and 27 were
observed (SIR=0.83; 95%CI: 0.55, 1.21).
Using these registers for reference, the SIR in
the Beaumont-Hague electoral ward in 5 to 9
year old group is smaller (SIR=4.62; 95%CI:
0.95, 13.49; 0.65 expected cases). Because of a
more accurate data collection, the paediatric
registers give reference incidence rates higher
than those from general population registers.
Indeed, the expected number of cases of acute
lymphoblastic leukaemia in the 5 to 9 year old
group calculated from the paediatric registers
is higher than the expected numbers in the
same age group of all forms of leukaemia
calculated from the general population regis-
ters.
Linear interpolations between census dates
provide an inaccurate estimate of the popula-
tion because there was substantial migration to
and from the study region. During the study
period, there were two major building projects
in the Nord Cotentin region: the nuclear power
station at Flamanville (1978 to 1986) and the
construction of a new nuclear waste reprocess-
ing unit on the La Hague site (1982 to 1991).
The diagonal interpolation method we used
takes account of the aging of the population
and of the numbers of births and deaths.15 The
methodological options taken for both the esti-
mation of the at risk population and the refer-
ence incidence rate explained the higher
expected number obtained in this study as
compared with the previous ones.6 7
Acute lymphoblastic leukaemias are the
most prevalent forms of leukaemia among
those under 15 years old, and account for the
peak in leukaemia incidence observed in young
children in industrialised countries.22 In our
study, there were four cases of acute lympho-
blastic leukaemia in 1 to 6 year olds in
Beaumont-Hague, whereas the number ex-
pected from the Lorraine paediatric register is
Table 5 Numbers of observed (O) and expected (E) cases of acute lymphoblastic leukaemia (ALL) by five year age group, and of acute myeloblastic
leukaemia (AML) in the 0 to 14 year old group (reference incidence rates from the paediatric registers of Lorraine and Provence-Alpes-Côtes-d’Azur and
Corsica regions)
Zones
Cytological type and age (y)
ALL, 0 to 4 ALL, 5 to 9 ALL, 10 to 14 ALL, 0 to 14 AML, 0 to 14
O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI
0 to 10 km 1 0.89 1.12 0.03, 6.26 3 0.52 5.77 1.19, 16.86 0 0.25 0.00 0.00, 14.75* 4 1.66 2.41 0.66, 6.17 0 0.27 0.00 0.00, 13.66*
10 to 20 km 3 8.24 0.36 0.08, 1.06 2 4.28 0.47 0.06, 1.69 3 2.03 1.48 0.30, 4.32 8 14.55 0.55 0.24, 1.08 4 2.36 1.70 0.46, 4.34
20 to 35 km 4 5.06 0.79 0.22, 2.02 3 3.01 1.00 0.21, 2.91 2 1.58 1.27 0.15, 4.57 9 9.65 0.93 0.43, 1.77 1 1.60 0.63 0.02, 3.48
entire study zone:
0 to 35 km 8 14.19 0.56 0.24, 1.11 8 7.81 1.02 0.44, 2.02 5 3.86 1.30 0.42, 3.02 21 25.86 0.81 0.50, 1.24 5 4.24 1.18 0.38, 2.75
*One tail, 97.5% confidence intervals.
472 Guizard, Boutou, Pottier, et al
www.jech.com
0.96 (SIR=4.17; 95%CI: 1.14, 10.67).20 The
incidence of acute myeloblastic leukaemia is
more regular during childhood. These observa-
tions motivated our detailed analysis of cyto-
logical types of leukaemia. In Beaumont-
Hague, the excess number of cases of
leukaemia seems to be entirely due to the 2.48
excess cases of acute lymphoblastic leukaemia
in the 5 to 9 year old group. For the 1 to 6 year
old group, the excess was 3.04 over a period of
21 years. For acute myeloblastic leukaemia, the
number of cases was insuYcient to detect any
excess.
Although the La Hague plant began its
reprocessing activities in 1966, it was techni-
cally impossible to reconstruct the incidence of
childhood leukaemia before 1978. A mortality
study had been conducted for the years 1968 to
1978.5 For the overall Nord Cotentin area, no
excess mortality was observed with no death
from leukaemia in the Beaumont-Hague elec-
toral ward. Although mortality is a crude indi-
cator of morbidity for childhood leukaemia,
this result may indicate that nothing dramatic
occurred around La Hague in the period prior
to 1978, when the site was operational.
There have been three previous studies of
the incidence of leukaemia in the neighbour-
hood of La Hague for the periods 1978–90,6
1978–92,7 and 1978–1996.25 Though these
suggested a small excess of childhood leukae-
mia in comparison with expected, the numbers
in each study were very small, and the results
therefore somewhat equivocal, leading to the
conclusion that it was important that the situa-
tion be kept under review. This is the major
reason for this study. All cases diagnosed before
1997 (table 3) had already been included in
previous analyses. The period 1993–1998 is
too short to be analysed separately from the
period 1978 to 1992, especially when consider-
ing detailed age classes and cytological types of
leukaemia. Adding this period confirmed that
the incidence of leukaemia in young people in
the Beaumont-Hague electoral ward was quite
high (SIR=2.17) and showed that it consisted
mainly in acute lymphoblastic leukaemia oc-
curring during the childhood incidence peak.
Our data have already been partially ana-
lysed, which increases the risk of erroneously
concluding that there is an excess. Multiple
comparisons performed by age, zone and,
cytological type could give rise to at least one
significant result by chance alone. In these cir-
cumstances, the type I error is not controlled
anymore and confidence limits should be
regarded only as numerical indices providing
guidance for further research. Our findings are
consistent with those in similar circumstances:
near Dounreay where the SIR is 3.3,26 and at
Seascale where the SIR is 10.2.1
Several possibilities have been suggested to
explain the excess number of cases of leukae-
mia observed around nuclear reprocessing
plants. They include paternal exposure to
radioactivity prior to conception,27 environ-
mental exposure to radioactivity,8 and popula-
tion movements.28 As the results of the
case-control study by Gardner et al had never
been reproduced, the hypothesis of paternal
preconceptional exposure to ionising radiation
was dismissed.29 Moreover, the case-control
study by Pobel and Viel was not in favour of
this hypothesis.8
A study of environmental radiation con-
cluded that it is very unlikely that exposure to
radioactive discharge from the nuclear installa-
tions in Nord Cotentin could cause a detect-
able increase in the incidence of leukaemia in
Beaumont-Hague30: of the four cases observed
from 1978 to 1996, 0.83 could be attributed to
ionising radiation, including only 0.0015 due
to radioactive discharge from the various
nuclear installations in Nord Cotentin. Al-
though the results seemed robust, they corres-
pond to an average estimation and some
reserves have been expressed about the lack of
an uncertainty analysis. Genetic susceptibility
has been evoked as an eVect modifier that
could potentiate the eVect of ionising radia-
tion.31
Dickinson and Parker recently quantified the
association between the occurrence of child-
hood leukaemia and non-Hodgkin’s
lymphoma, and population mixing among
children born in Cumbria.23 The association
was all the more stronger when acute lympho-
blastic leukaemia among children aged 1 to 6
years were examined. Our study indicates the
predominance of acute lymphoblastic leukae-
mia over childhood leukaemia cases diagnosed
in the Beaumont-Hague electoral ward. Al-
though not conclusive, this observation could
be linked to the dramatic intensity of popula-
tion movement that occurred in this particular
area. A study is currently underway to analyse
population movement and childhood leukae-
mia in Nord Cotentin. Indeed, it currently
seems diYcult to dissociate the correlation
between the incidence of leukaemia and prox-
imity to the plant from that between leukaemia
and population movements.
Several diseases increase the risk of leukae-
mia.32 33 Individuals with Down’s syndrome
have a 10-fold to 18-fold increased for leukae-
mia, FAB M7 megacaryoblastic subtype before
3 years and acute lymphoblastic leukaemia
after 3 years of age.32 In our study, three
patients suVered Down’s syndrome and devel-
oped acute leukaemia: two of them were acute
lymphoblastic leukaemia, the third one could
not be characterised. It could have been inter-
esting to produce the analysis without cases
KEY POINTS
x Surveillance of childhood and young
adulthood leukaemia around the La
Hague nuclear waste reprocessing plant
continued until 1998.
x An increased incidence of leukaemia is
reported in the 5 to 9 years age group in
the nearest area from the site.
x Analysis of cytological type shows that
this increased incidence could be attribut-
able mostly to acute lymphoblastic leu-
kaemia.
x No cases were observed on Alderney
from 1978 to 1998.
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suVering Down’s syndrome. However, leukae-
mia reference incidence rates excluding pa-
tients with Down’s syndrome are not available
in France. Moreover, no patient with Down’s
syndrome was living in the Beaumont-Hague
electoral ward when diagnosed. Exclusion of
patients with Down’s syndrome from the
analysis could increase the SIR in this particu-
lar area. The 35 other patients presented no
clinical or history evidence for trisomy 8
syndrome, Bloom syndrome, ataxia tel-
angiectasia, Fanconi anaemia, Li-Fraumeni or
immunodeficiency syndromes. Neither was a
pure familial leukaemia observed in these
patients.
In view of statistically significant clusters of
childhood leukaemia near other European
nuclear reprocessing sites, and the concerns of
the local population, these findings argue in
favour of continued investigations in Nord
Cotentin. Three lines should be followed:
measuring the incidence of child leukaemia
among people who have lived at any time in
Beaumont-Hague; identifying possible causes
of leukaemia in the area (studies of population
movements); and measuring the incidence of
other diseases the occurrence of which could
be linked to radiation (other cancers, and
reproductive function disorders).
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